Genmab A/S (GMAB) Financials
GMAB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 5.2 billion | 544.7 million |
2023-09-30 | 5.0 billion | 585.0 million |
2023-06-30 | 4.7 billion | 470.8 million |
2023-03-31 | 4.4 billion | 469.1 million |
GMAB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 237.6 million | ? |
2023-09-30 | 274.9 million | 23.0 million |
2023-06-30 | 48.1 million | 22.8 million |
2023-03-31 | 458.4 million | 16.8 million |
GMAB Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 94.7 million |
2023-09-30 | 383.1 million |
2023-06-30 | 251.7 million |
2023-03-31 | 41.9 million |
GMAB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 4.2 billion | - | 114.0 million |
2023-09-30 | 3.9 billion | - | 112.4 million |
2023-06-30 | 3.6 billion | - | 117.3 million |
2023-03-31 | 3.6 billion | - | 121.4 million |
GMAB Shares Outstanding
GMAB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 9.9 million | 288.4 million | 138.3 million | - |
2023-09-30 | 13.9 million | 296.1 million | 119.0 million | - |
2023-06-30 | 15.6 million | 270.7 million | 123.9 million | - |
2023-03-31 | 15.2 million | 254.9 million | 99.0 million | - |
GMAB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 692.6 million | 18.7 million |
2023-09-30 | 672.6 million | 14.2 million |
2023-06-30 | 613.3 million | - |
2023-03-31 | 417.8 million | - |
GMAB
Price: $30.26
52 week price:
Earnings Per Share: 1.20 USD
P/E Ratio: 29.54
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 221594
Market Capitalization: 18.6 billion